These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12622551)

  • 21. Oncogenes, molecular biology and the head and neck surgeon.
    Irish JC
    J Otolaryngol; 1992 Dec; 21 Suppl 3():1-20. PubMed ID: 1289578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of head and neck squamous cell cancer biomarkers.
    Polanska H; Raudenska M; Gumulec J; Sztalmachova M; Adam V; Kizek R; Masarik M
    Oral Oncol; 2014 Mar; 50(3):168-77. PubMed ID: 24382422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic biomarkers in head and neck cancer.
    Grandis JR
    Clin Cancer Res; 2006 Sep; 12(17):5005-6. PubMed ID: 16951212
    [No Abstract]   [Full Text] [Related]  

  • 24. [Gene expression analyses and their possible clinical benefit in head and neck cancer].
    Dietz A; Loeffler M; Rosolowski M; Kreuz M; Lordick F; Knödler M; Mozet C; Wichmann G
    HNO; 2015 Nov; 63(11):773-85. PubMed ID: 26471186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miRNA profiling of primary lung and head and neck squamous cell carcinomas: Addressing a diagnostic dilemma.
    Muñoz-Largacha JA; Gower AC; Sridhar P; Deshpande A; O'Hara CJ; Yamada E; Godfrey TE; Fernando HC; Litle VR
    J Thorac Cardiovasc Surg; 2017 Aug; 154(2):714-727. PubMed ID: 28495058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Papillomavirus-Related Head and Neck Cancer.
    Wagner S; Sharma SJ; Wuerdemann N; Knuth J; Reder H; Wittekindt C; Klussmann JP
    Oncol Res Treat; 2017; 40(6):334-340. PubMed ID: 28521311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular markers of head and neck cancer].
    Temam S; Janot F
    Rev Prat; 2006 Oct; 56(15):1658-61. PubMed ID: 17137250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is gene expression profiling of head and neck cancers ready for the clinic?
    Ziober AF; D'Alessandro L; Ziober BL
    Biomark Med; 2010 Aug; 4(4):571-80. PubMed ID: 20701444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of advances in molecular genetic pathology on the classification, diagnosis and treatment of selected soft tissue tumors of the head and neck.
    García JJ; Folpe AL
    Head Neck Pathol; 2010 Mar; 4(1):70-6. PubMed ID: 20237992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2010 Multidisciplinary Head and Neck Cancer Symposium.
    Huang SH; O'Sullivan B
    Expert Rev Anticancer Ther; 2010 May; 10(5):651-3. PubMed ID: 20469996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions.
    van Houten VM; Tabor MP; van den Brekel MW; Denkers F; Wishaupt RG; Kummer JA; Snow GB; Brakenhoff RH
    Clin Cancer Res; 2000 Oct; 6(10):3803-16. PubMed ID: 11051222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease.
    Gollin SM
    Genes Chromosomes Cancer; 2014 Dec; 53(12):972-90. PubMed ID: 25183546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liquid Biopsy: A Future Tool for Posttreatment Surveillance in Head and Neck Cancer?
    van Ginkel JH; Huibers MMH; Noorlag R; de Bree R; van Es RJJ; Willems SM
    Pathobiology; 2017; 84(3):115-120. PubMed ID: 27974721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Motility-related proteins as markers for head and neck squamous cell cancer.
    Abraham MT; Kuriakose MA; Sacks PG; Yee H; Chiriboga L; Bearer EL; Delacure MD
    Laryngoscope; 2001 Jul; 111(7):1285-9. PubMed ID: 11568556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNAs Involvement in Radioresistance of Head and Neck Cancer.
    Ahmad P; Sana J; Slavik M; Slampa P; Smilek P; Slaby O
    Dis Markers; 2017; 2017():8245345. PubMed ID: 28325958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Crystallization test in patients with head and neck neoplasms].
    Kuczkowski J; Zaorski P; Betlejewski A
    Otolaryngol Pol; 1995; 49 Suppl 20():121-4. PubMed ID: 9454116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modern molecular biomarkers of head and neck cancer. Part I. Epigenetic diagnostics and prognostics: Systematic review.
    Juodzbalys G; Kasradze D; Cicciù M; Sudeikis A; Banys L; Galindo-Moreno P; Guobis Z
    Cancer Biomark; 2016; 17(4):487-502. PubMed ID: 27802200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular genetics of head and neck cancer.
    Gleich LL; Salamone FN
    Cancer Control; 2002; 9(5):369-78. PubMed ID: 12410176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
    Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
    Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic accuracy of serum biomarkers for head and neck cancer: A systematic review and meta-analysis.
    Guerra EN; Rêgo DF; Elias ST; Coletta RD; Mezzomo LA; Gozal D; De Luca Canto G
    Crit Rev Oncol Hematol; 2016 May; 101():93-118. PubMed ID: 26971993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.